Sylvia Gografe

Title: Sylvia Gografe: Innovator in Prenatal Treatment

Introduction

Sylvia Gografe is a pioneering inventor based in Nashville, TN (US). She has made significant contributions to the field of prenatal medicine, particularly in the treatment of congenital conditions. Her innovative approach has the potential to change the lives of many families facing genetic challenges.

Latest Patents

Sylvia Gografe holds a patent for a groundbreaking method titled "Method of prenatal administration of mammalian umbilical cord stem cells for the intrauterine treatment of Sanfilippo syndrome." This method involves treating a fetus or embryo suspected of having a congenital condition that involves an abnormal or missing protein. The process includes providing a plurality of human umbilical cord blood in a form suitable for intravenous administration and administering these cells to a mother carrying a fetus or embryo suspected of having the condition. The congenital conditions addressed by this method include Sanfilippo's syndrome, Hunter's syndrome, Hurler's syndrome, Tay-Sachs disease, Gaucher's disease, von Gierke's disease, Pompe's disease, Cori disease, Andersen disease, McArdle's disease, Hers disease, Tauri's disease, or Type IX glycogen storage disease.

Career Highlights

Sylvia Gografe is affiliated with the University of South Florida, where she continues her research and development in prenatal treatments. Her work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

Sylvia collaborates with esteemed colleagues such as Svitlana Garbuzova-Davis and Paul R Sanberg. Their combined expertise enhances the research and development of innovative medical solutions.

Conclusion

Sylvia Gografe's contributions to prenatal medicine through her patented methods exemplify the impact of innovation in healthcare. Her work not only addresses critical medical challenges but also offers hope to families affected by genetic disorders.